Epidolex may be the first FDA-approved, cannabis-based pharma product on the market. But over-the-counter, hemp-based CBD products will take a large bite out of that market as it continues to show similar effects as the price, prescription-based brand.
New Jersey will be bring in recreational cannabis money at the register by 2019 - others will follow. That's why the East Coast is becoming the market to watch and could surpass California's market size.
Not all IPOs are created equal. The biggest winners, the next Tilray, are going to thrive in at least one of three key areas of focus. These are areas where companies can truly differentiate themselves from the crowd.
Doctors, researchers, veterans who use cannabis, and a prominent professional athlete talk to the National Institute for Cannabis Investors about PTSD and how much cannabis-based products can help in treating the disease.
It's difficult to see a stock you recently bought go down. But as those who sold during Canopy Growth's three significant declines dating back to 2015 would attest, now is not the time to lose our resolve.
The eyes of the cannabis industry continue to shift east, as Massachusetts opens its first recreational dispensaries. But a neighbor is trying to do something much bigger even without expanding beyond medical use.
The biggest change in federal cannabis law is coming in 2019 and it will open up a wave of new opportunity for businesses. And that's not even the most important part of what our inside source has to say. (Read more)